P391: PROGNOSTIC ANALYSIS OF RELAPSED PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA TREATED BY CCLG-ALL2008 PROTOCOL IN CHINA

P391: PROGNOSTIC ANALYSIS OF RELAPSED PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA TREATED BY CCLG-ALL2008 PROTOCOL IN CHINA

Bibliographic Details
Main Authors:	Ning Wang, Xiao-Juan Chen, Xiao-Fan Zhu
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000968472.48671.02

Similar Items

Dual intra- and extracranial lymphoblastic chloromas in relapsed Pediatric Acute Lymphoblastic Leukemia
by: Kainaat Javed, et al.
Published: (2022-03-01)

Pulmonary embolism in acute lymphoblastic leukemia — An observational study of 1685 patients treated according to the NOPHO ALL2008 protocol
by: Ruta Tuckuviene, et al.
Published: (2020-07-01)

Minimal residual disease prognostic value for relapse-free survival of children with acute lymphoblastic leukemia treating according to ALL-MB-2002 protocol (monofactorial and multifactirial analysis)
by: N. N. Savva, et al.
Published: (2022-11-01)

Cost-analysis of Treatment of Pediatrics Acute Lymphoblastic Leukemia based on ALL-BFM Protocol
by: Hadi Hayati, et al.
Published: (2016-09-01)

Prognostic significance of steroid response in pediatric acute lymphoblastic leukemia: The CCCG-ALL-2015 study
by: Jinhua Chu, et al.
Published: (2022-12-01)

Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemia
by: Han Wang, et al.
Published: (2023-10-01)

Late relapsing childhood lymphoblastic leukemia.
by: Vora, A, et al.
Published: (1998)

Testicular relapse of acute lymphoblastic leukemia
by: Alexandra Carolan, et al.
Published: (2023-09-01)

The Prognostic Effect of CDKN2A/2B Gene Deletions in Pediatric Acute Lymphoblastic Leukemia (ALL): Independent Prognostic Significance in BFM-Based Protocols
by: Mirella Ampatzidou, et al.
Published: (2023-04-01)

Malignant DFFB isoform switching promotes leukemia survival in relapse pediatric T‐cell acute lymphoblastic leukemia
by: Sabina Enlund, et al.
Published: (2023-02-01)

Clinical summary of pediatric acute lymphoblastic leukemia patients complicated with asparaginase-associated pancreatitis in SCCLG-ALL-2016 protocol
by: Jian Wang, et al.
Published: (2023-12-01)

Intraocular relapse of childhood acute lymphoblastic leukemia.
by: Somervaille, T, et al.
Published: (2002)

INFECTIONS ON DIFFERENT CHEMOTHERAPY CYCLES IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH ALL-2009 PROTOCOL
by: V. A. Okhmat, et al.
Published: (2017-10-01)

Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia
by: Judit C. Sági, et al.
Published: (2021-05-01)

Development of an immune‐related prognostic model for pediatric acute lymphoblastic leukemia patients
by: Xi Quan, et al.
Published: (2020-09-01)

PB1745: SURVIVAL AND PROGNOSTIC FACTORS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA IN OMAN.
by: Moza Almamari, et al.
Published: (2023-08-01)

Unravelling the Sequential Interplay of Mutational Mechanisms during Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia
by: Željko Antić, et al.
Published: (2021-02-01)

Prognostic impact of CD200 expression in pediatric B-cell acute lymphoblastic leukemia
by: Mustafa Jassim Alwan, et al.
Published: (2021-01-01)

PB1764: THE CHARACTERISTICS, TREATMENT PATTERNS, AND SURVIVAL OF ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) TREATED BY GRAALL OR GRAAPH PROTOCOL
by: Y. Fakhfakh, et al.
Published: (2022-06-01)

Prognostic factors of children’s acute lymphoblastic leukemia therapy in Moscow—Berlin protocols
by: J. V. Roumiantseva, et al.
Published: (2022-11-01)

Copy Number Alteration Profile Provides Additional Prognostic Value for Acute Lymphoblastic Leukemia Patients Treated on BFM Protocols
by: Μirella Αmpatzidou, et al.
Published: (2021-06-01)

Relapses Children’s Acute Lymphoblastic Leukemia, Single Center Experience
by: Weronika Stolpa, et al.
Published: (2022-11-01)

Acute lymphoblastic leukemia relapse presenting with optic nerve infiltration
by: Gianluca Dini, et al.
Published: (2023-05-01)

Upfront Treatment Influences the Composition of Genetic Alterations in Relapsed Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
by: Jiangyan Yu, et al.
Published: (2020-02-01)

Blinatumomab as a Bridge Therapy for Hematopoietic Stem Cell Transplantation in Pediatric Refractory/Relapsed Acute Lymphoblastic Leukemia
by: Katarzyna Pawinska-Wasikowska, et al.
Published: (2022-01-01)

Precursor B-cell acute lymphoblastic leukemia presenting with isolated skin relapse: a pediatric case report
by: Yeter Düzenli Kar, et al.
Published: (2023-05-01)

Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era
by: Shang Mengxuan, et al.
Published: (2022-06-01)

Short-course blinatumomab for refractory/relapse precursor B acute lymphoblastic leukemia in children
by: Jiao Xie, et al.
Published: (2023-08-01)

Cytogenetics and Molecular Genetics in Pediatric Acute Lymphoblastic Leukemia (ALL) and Its Correlation with Induction Outcomes
by: Ajeitha Loganathan, et al.
Published: (2022-10-01)

Upregulation of T-Cell-Specific Transcription Factor Expression in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL)
by: Müge Sayitoğlu, et al.
Published: (2012-12-01)

Toxicity assessment of acute lymphoblastic leukemia treatment protocol ALL IC-BFM 2002
by: T. T. Valiev, et al.
Published: (2022-07-01)

Dermatological toxicity of acute lymphoblastic leukemia treatment by protocol ALL IC-BFM 2002
by: Timur T. Valiev, et al.
Published: (2022-08-01)

Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase
by: Maria Agustina Perusini, et al.
Published: (2024-12-01)

Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols
by: Pere Barba, et al.
Published: (2023-01-01)

P394: FRONTLINE COMBINATION OF OLVEREMBATINIB AND PDT-ALL-2016 PEDIATRIC INSPIRED PROTOCOL IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
by: Kaibo Zhu, et al.
Published: (2023-08-01)

Pediatric acute lymphoblastic leukemia treatment protocols improvement: emphasis on minimal residual disease
by: M. A. Shervashidze, et al.
Published: (2020-10-01)

Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab
by: Hagop M. Kantarjian, et al.
Published: (2023-10-01)

P501: ISATUXIMAB PLUS CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA (ISAKIDS): INTERIM EFFICACY ANALYSIS
by: André Baruchel, et al.
Published: (2023-08-01)

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.
by: Fielding, A, et al.
Published: (2007)

Blinatumomab for treating pediatric B-lineage acute lymphoblastic leukemia: A retrospective real-world study
by: Ying Wu, et al.
Published: (2022-10-01)